These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24012972)

  • 1. Potential drug interventions for diabetic retinopathy.
    Shen Q; Wu JZ; Wong JC
    Drug Discov Today; 2013 Dec; 18(23-24):1334-41. PubMed ID: 24012972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: possible therapeutic targets for the treatment of diabetic retinopathy: evidences from experimental models.
    de Faria JM; Duarte DA
    Curr Clin Pharmacol; 2013 Nov; 8(4):265. PubMed ID: 23173955
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy.
    Kwa FA; Thrimawithana TR
    Drug Discov Today; 2014 Sep; 19(9):1387-93. PubMed ID: 24717156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of retinal diseases and their applicability in drug discovery.
    Malek G; Busik J; Grant MB; Choudhary M
    Expert Opin Drug Discov; 2018 Apr; 13(4):359-377. PubMed ID: 29382242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
    Cai J; Ruan Q; Chen ZJ; Han S
    Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
    Pruneau D; Bélichard P; Sahel JA; Combal JP
    Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kallikrein-kinin system as a target for diabetic retinopathy treatment].
    Iarovaia GA; Neshkova EA; Blokhina TB; Kochergin SA; Vorob'eva IV; Gigineishvili DN
    Vestn Oftalmol; 2012; 128(4):78-81. PubMed ID: 22994115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals.
    Robinson R; Barathi VA; Chaurasia SS; Wong TY; Kern TS
    Dis Model Mech; 2012 Jul; 5(4):444-56. PubMed ID: 22730475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011.
    Jee D; Lee WK; Kang S
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6827-33. PubMed ID: 24065813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current nanotechnology approaches for the treatment and management of diabetic retinopathy.
    Fangueiro JF; Silva AM; Garcia ML; Souto EB
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):307-22. PubMed ID: 25536109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.
    Wang FH; Liang YB; Zhang F; Wang JJ; Wei WB; Tao QS; Sun LP; Friedman DS; Wang NL; Wong TY
    Ophthalmology; 2009 Mar; 116(3):461-7. PubMed ID: 19168222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy: an Indian perspective.
    Rema M; Pradeepa R
    Indian J Med Res; 2007 Mar; 125(3):297-310. PubMed ID: 17496357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models of Diabetic Retinopathy.
    Jiang X; Yang L; Luo Y
    Curr Eye Res; 2015; 40(8):761-71. PubMed ID: 25835487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
    Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
    Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and risk factors of diabetic retinopathy in children and young adults].
    Ben Hamouda H; Messaoud R; Grira S; Ayadi A; Khairallah M; Soua H; Sfar MT
    J Fr Ophtalmol; 2001 Apr; 24(4):367-70. PubMed ID: 11351208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.